An explosion of health information is disrupting almost every aspect of the product life cycle, from R&D to commercialization, and is driving value-based, personalized treatment trends. As a result, our life sciences clients are adopting new approaches for sharing and analyzing information to improve results in their R&D processes. For example, a recent Deloitte survey found that 87% of major biopharmas either have a program underway or plan to begin one in 2017.
Life sciences companies can use this Real World Evidence (RWE) to better understand what’s happening during episodes of care at a much larger scale than is possible with clinical trials. For example, it can enable researchers to characterize patient experience with a condition and therapy across millions of patients versus the few thousand that are typically part of clinical trials. Additionally, insights generated from RWE may affect decisions across the entire product life cycle, from R&D through commercialization. An end-to-end evidence management strategy could be a key ingredient in realizing RWE’s potential because it can help decision makers act at an enterprise level based on rigorous, data-driven insights, as opposed to a traditional, more siloed approach.
ConvergeHEALTH Miner connects silos of data to powerful analytics and visualization tools, enabling researchers to easily generate and explore hypotheses. The ability to query RWE and clinical data can be used to: understand risk-benefit profiles in the safety space; respond to regulators quickly; replicate clinical trials for enhanced patient understanding; drive acceleration and approvals in single arm trials; conduct comparative effectiveness studies; and inform business development and portfolio strategies.
Cloudera’s Enterprise Data Hub is central to the ConvergeHEALTH Miner suite and enables exploratory and analytical workloads through extensive use of Impala and Spark.
Drive customer insights
The ConvergeHEALTH suite of products is built with the understanding that, in today’s market, truly actionable insights are derived from a combination of real-world information, evidence, and experience—not just data. Powered by Deloitte’s unparalleled industry experience, our solutions are designed specifically to solve the biggest business and operational challenges facing the health care and life science industries.